GoodRx Holdings Inc.

# Signal Note: Deerfield Initiates GoodRx Position Deerfield Management's $1.8M entry into GDRX suggests conviction in the discount pharmacy platform's margin expansion thesis, likely driven by improving unit economics post-IPO stabilization and potential upside from pharmacy services diversification (telehealth, patient engagement). The position size (~660K shares) indicates measured conviction rather than conviction play, positioning Deerfield to benefit from operational leverage as GDRX scales its membership base and ancillary services beyond price transparency. No imminent catalyst evident, suggesting thesis is medium-term operational improvement and market share consolidation in consumer pharmacy services.